Professor
Royal Marsden Hospital, United Kingdom
I am Professor of Sarcoma and Melanoma Surgery at the Royal Marsden Hospital and the Institute of Cancer Research in London , UK. I qualified in medicine from Oxford University /St Bartholomew's Hospital, London in 1990 then undertook my surgical residency in London and a PhD in the Lombardi Cancer Center, Georgetown University Washington DC from 1996 to 2000. I did my fellowship in Surgical Oncology at the Royal Marsden from 2002 until I was appointed as a Consultant Surgeon on the Sarcoma and Skin Cancer units in 2004. I have a specialist surgical practice in limb and retroperitoneal soft-tissue sarcoma and advanced melanoma and other rare cutaneous malignancies. I operate on about 200 cases of sarcoma and 100 cases of complex skin malignancies a year. I run the Isolated Limb Perfusion (ILP) programme in the Royal Marsden which provides a national service for regional chemotherapy for patients in the UK. From 2019 to 2022 I was President of the British Sarcoma Group and continue on the executive committee of that group. I am the Clinical Director for Rare Cancers in the Royal Marsden Hospital. My laboratory research is based at the Institute of Cancer Research, the partner research institute to the Royal Marsden, where I investigate oncolytic virotherapy delivered by ILP as a potential new strategy for the treatment of advanced limb sarcomas, and I also run phase I/II clinical studies in the Royal Marsden in oncolytic virotherapy delivered by ILP.
